Background-This study examined the effects of chronic amlodipine treat
ment on left ventricular (LV) pump function, systemic hemodynamics, ne
urohormonal status, and regional blood flow distribution in an animal
model of congestive heart failure (CHF) both at rest and with treadmil
l exercise. In an additional series of in vitro studies, LV myocyte co
ntractile function was examined. Methods and Results-Sixteen pigs were
studied under normal control conditions and after the development of
chronic pacing-induced CHF (240 bpm, 3 weeks, n=8) or chronic pacing a
nd amlodipine (1.5 mg.kg(-1).d(-1), n=8). Under ambient resting condit
ions, LV stroke volume (mL) was reduced with CHF compared with the nor
mal control state (16+/-2 versus 31+/-2, P<0.05) and increased with co
ncomitant amlodipine treatment (29+/-2, P<0.05). At rest, systemic and
pulmonary vascular resistance (dyne.s(-1).cm(-5)) increased with CHF
compared with the normal control state (3102+/-251 versus 2156+/-66 an
d 1066+/-140 versus 253+/-24, respectively, both P<0.05) and were redu
ced with amlodipine treatment (2108+/-199 and 480+/-74, respectively,
P<0.05). With CHF, LV stroke volume remained reduced and was associate
d with a 40% reduction in myocardial blood flow during treadmill exerc
ise, whereas chronic amlodipine treatment normalized LV stroke volume
and improved myocardial blood flow. Resting and exercise-induced plasm
a norepinephrine levels were increased by >5-fold in the CHF group and
were reduced by 50% from CHF values with chronic amlodipine treatment
. Resting plasma endothelin (fmol/mL) increased with CHF compared with
the normal state (10.4+/-0.9 versus 3.1+/-0.3, P<0.05) and was reduce
d with amlodipine treatment (6.6+/-1.1, P<0.5). With CHF, LV myocyte v
elocity of shortening (mu m/s) was reduced compared with normal contro
ls (39+/-1 versus 64+/-1, P<0.05) and was increased with chronic amlod
ipine treatment (52+/-1, P<0.05). Conclusions-Chronic amlodipine treat
ment in this model of developing CHF produced favorable hemodynamic, n
eurohormonal, and contractile effects in the setting of developing CHF
.